Severe Graves' disease‐associated orbitopathy: A rare case of frontal bone hemangioma

Graves' orbitopathy might be severe, requiring treatment with high‐dose glucocorticoids. A lytic bone lesion, malignant lesions, and diseases resulting from bone remodeling processes (eg, Paget's disease) must be excluded by markers and imagery. Outcomes of high‐dose glucocorticoids and th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical case reports 2021-02, Vol.9 (2), p.787-789
Hauptverfasser:	Alamri, Ahmad, Pauchet, Daphné, Balaton, André, Oriez, Constance, Dupuy, Olivier, Ben Hamou, Adrien
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Case Report Case Reports frontal bone hemangioma Graves disease Graves’ disease‐associated orbitopathy Hemangioma intravenous glucocorticoids Magnetic resonance imaging Medical imaging Patients Thyroid gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Graves' orbitopathy might be severe, requiring treatment with high‐dose glucocorticoids. A lytic bone lesion, malignant lesions, and diseases resulting from bone remodeling processes (eg, Paget's disease) must be excluded by markers and imagery. Outcomes of high‐dose glucocorticoids and thyrotoxicosis must be screened and prevented. Graves' orbitopathy might be severe, requiring treatment with high‐dose glucocorticoids. A lytic bone lesion, malignant lesions, and diseases resulting from bone remodeling processes (eg, Paget's disease) must be excluded by markers and imagery. Outcomes of high‐dose glucocorticoids and thyrotoxicosis must be screened and prevented.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.3638